Cargando…
Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis
Tumor-derived nanovesicles have been widely used as a biomarker or therapeutic target in various tumor types. However, these nanovesicles have limited use in therapy due to the risk of advancing tumor development. Methods: Exosome-like nanovesicles (ENVs) were developed from metastatic breast cancer...
Autores principales: | Qiu, Xiaolan, Li, Zhi, Han, Xuedong, Zhen, Linlin, Luo, Chao, Liu, Minmin, Yu, Kun, Ren, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525995/ https://www.ncbi.nlm.nih.gov/pubmed/31131057 http://dx.doi.org/10.7150/thno.32363 |
Ejemplares similares
-
Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors
por: Leal, Baltazar Hiram, et al.
Publicado: (2022) -
Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017) -
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
por: Xu, Gao-Xin, et al.
Publicado: (2023) -
Chemiluminescence detection of reactive oxygen species in isolated Kupffer cells during phagocytosis of Treponema pallidum
por: Aldini, Rita, et al.
Publicado: (2004) -
Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors
por: Qamar, Hina, et al.
Publicado: (2021)